Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19
NCT ID: NCT05238623
Last Updated: 2025-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
50 participants
OBSERVATIONAL
2025-10-01
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19
NCT05441657
Physiological Behavior of Respiratory Maneuvers
NCT03270826
Evaluation of Postoperative Ventilation Distribution With Electrical Impedance Tomography
NCT05389735
Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure
NCT04534400
EIT Assessment of Lung Volume and Tidal Distribution: A Comparison of Non-Invasive Ventilation Devices
NCT02930174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control cohort
lung-healthy volunteers get a EIT measurement
No interventions assigned to this group
Case cohort
Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement
additional EIT Measurement
Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
additional EIT Measurement
Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>18 years
* informed consent.
Exclusion Criteria
* patients with an BMI over 50
* patients with uncontrolled body movements
* Patients with a pacemaker
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jan-Christoph Lewejohann
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan-Christoph Lewejohann
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phillip A Reuken, Dr.
Role: STUDY_DIRECTOR
Jena University Hospital, Klinik für Innere Medizin IV
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Notfallmedizin
Jena, Thuringia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KIM-IV-EIT03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.